SERA PROGNOSTICS INC reports a Return on Equity (ROE) of -47.53%.

What is SERA's dividend yield?

SERA PROGNOSTICS INC offers a dividend yield of 0.00%.

What is SERA's Quality Score?

Our AI rates SERA's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy SERA?

Our AI Timing Score for SERA is 5 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does SERA belong to?

SERA PROGNOSTICS INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

SERA (NASDAQ) Stock Analysis | SERA PROGNOSTICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

SERA AI Analysis Summary

Our AI summary for SERA: SERA PROGNOSTICS INC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -47.53%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 5/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SERA

SERA PROGNOSTICS INC

US:NASDAQ STOCK Healthcare >> Medical Devices News 96

USD 2.04

-0.06 (-2.86%) Day Change

Watchlist Portfolio Compare Chart

0.38

D/E

-47.5%

ROE

-34.4%

ROA

0.00%

Div Yield

SERA PROGNOSTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.04 Price -0.06 (-2.86%) Day Change	NEWS SCORE: 96

SERA, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.04
PBV / Sector	1.22 / -101.57 GOOD
Earning Per Share	-0.80

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	0.08 M GREAT
Average 1W Daily Value	0.09 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-56,385.96 / 20.50
NPM Average (%) / Sector	-33,371.81 / -15.37
NPM Change Average (%) / Sector	66.97 / 7.34 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-34.36 / 39.11
ROA Average (%) / Sector	-37.39 / 5.58
ROA Change Average (%) / Sector	-0.47 / 104.50
ROE (%) / Sector	-47.53 / -166.42
ROE Average (%) / Sector	-51.00 / -16.93
ROE Change Average (%) / Sector	5.67 / -500.08
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 08:00:28
Symbol	SERA
Name	SERA PROGNOSTICS INC
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	38.19 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	82.23 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2749 East Parleys Way, Salt Lake City, UT, United States, 84109

Phone: 801 990 0520

Website: https://www.sera.com

Employees: 71

Sector: Healthcare >> Medical Devices

Description: Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.